2023-09-27 08:30:53 ET
- MillerKnoll ( MLKN ) +17% rides 18% higher, sees improving organic orders during FQ1.
- Gaucho Group Holdings ( VINO ) +15% .
- Ginkgo Bioworks Holdings ( DNA ) +16% Announces Multi-Target RNA Discovery Collaboration with Pfizer.
- Neptune Wellness Solutions ( NEPT ) +14% Closes US$4.5 Million Public Offering.
- Cardiff Oncology ( CRDF ) +13% up 12% on phase 2 data for pancreatic cancer candidate.
- Ocuphire Pharma ( OCUP ) +14% Announce FDA Approval of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% Eye Drops for the Treatment of Pharmacologically-Induced Mydriasis Produced by Adrenergic Agonists (e.g., Phenylephrine) or Parasympatholytic (e.g., Tropicamide) Agents.
- Connexa Sports Technologies ( CNXA ) +14% .
- Hayward Holdings ( HAYW ) +9% set to join S&P MidCap 400; Hayward Holdings to join S&P SmallCap 600.
- Scienjoy Holding ( SJ ) +9% .
- Blink Charging ( BLNK ) +8% .
- SoundHound ( SOUN ) +8% .
- Can-Fite Biopharma ( CANF ) +7% Approach for the Treatment of Pancreatic Carcinoma with Namodenoson Receives Appreciation of the American Association of Cancer Research (AACR).
- Allakos ( ALLK ) +7% .
- Bitfarms ( BITF ) +6% .
- Immunity ( IBRX ) +5% .
- WW International ( WW ) +5% .
For further details see:
BLNK, WW and IBRX are among pre market gainers